| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.4 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.041 | 0.4 |